Literature DB >> 15293062

The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients.

P F Yumuk, S Z Aydin, F Dane, M Gumus, M Ekenel, M Aliustaoglu, A Karamanoglu, M Sengoz, S N Turhal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15293062     DOI： 10.1007/s00384-004-0613-5

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN： 0179-1958            Impact factor:   2.571


× No keyword cloud information.
  4 in total

Review 1.  Muscarinic Receptors Associated with Cancer.

Authors:  Gloria M Calaf; Leodan A Crispin; Juan P Muñoz; Francisco Aguayo; Tammy C Bleak
Journal:  Cancers (Basel)       Date:  2022-05-07       Impact factor: 6.575

2.  HuangQin Decoction Attenuates CPT-11-Induced Gastrointestinal Toxicity by Regulating Bile Acids Metabolism Homeostasis.

Authors:  Xu Wang; Dong-Ni Cui; Xiao-Min Dai; Jing Wang; Wei Zhang; Zun-Jian Zhang; Feng-Guo Xu
Journal:  Front Pharmacol       Date:  2017-03-30       Impact factor: 5.810

Review 3.  Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.

Authors:  Femke M de Man; Andrew K L Goey; Ron H N van Schaik; Ron H J Mathijssen; Sander Bins
Journal:  Clin Pharmacokinet       Date:  2018-10       Impact factor: 6.447

4.  Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome.

Authors:  Hirotoshi Iihara; Hironori Fujii; Chiaki Yoshimi; Ryo Kobayashi; Nobuhisa Matsuhashi; Takao Takahashi; Kazuhiro Yoshida; Akio Suzuki
Journal:  Cancer Chemother Pharmacol       Date:  2018-12-18       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.